19th Annual International Ultmann Chicago Lymphoma Symposium

 

19th Annual International Ultmann Chicago Lymphoma Symposium
Avatar

Recent Advances in the Frontline Treatment of DLBCL: Is There a New Standard of Care?

By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING Laurie H. Sehn
By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING Laurie H. Sehn
485 views
July 8, 2022
0 Comments
Login to view comments. Click here to Login
Videos
15:36
19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of 1st Relapsed Classical Hodgkin Lymphoma

Feat. V. Kenkre
12:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Targeted Agents in Follicular Lymphoma: Small Molecules

Feat. T. Phillips
19:06
19th Annual International Ultmann Chicago Lymphoma Symposium

Primary CNS Lymphoma: Focus on Consolidation

Feat. T. Batchelor
20:01
19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Constructs in Lymphoma: Current and Future Options

Feat. T. Siddiqi
54:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Toxicities Associated With Chronic Therapies for Lymphoma: Case Stud…

Feat. N. Soriano, K. Thorp
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Fol…

Feat. S. Ahmed
20:03
19th Annual International Ultmann Chicago Lymphoma Symposium

Biology of Follicular Lymphoma

Feat. R. Kridel
25:29
19th Annual International Ultmann Chicago Lymphoma Symposium

Mantle Cell Lymphoma: Case-Based Approach to Management

Feat. R. Karmali
20:13
19th Annual International Ultmann Chicago Lymphoma Symposium

Bispecific Antibodies in Lymphomas

Feat. R. Bannerji
20:16
19th Annual International Ultmann Chicago Lymphoma Symposium

How to Sequence Non-CAR T-Cell Therapy for Relapsed DLBCL

Feat. D. Landsburg
19:22
19th Annual International Ultmann Chicago Lymphoma Symposium

Prevention of CNS Progression in DLBCL

Feat. C. Portell
19:28
19th Annual International Ultmann Chicago Lymphoma Symposium

Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Tre…

Feat. C. Steidl
19:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedoti…

Feat. A. Sureda
42:23
19th Annual International Ultmann Chicago Lymphoma Symposium

COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccinatio…

Feat. N. Pettit
24:15
19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of Relapsed CNS Lymphomas

Feat. A. Ferreri
24:14
19th Annual International Ultmann Chicago Lymphoma Symposium

Prognostication and Treatment of Burkitt Lymphoma in the Modern Era

Feat. A. Olszewski
48:49
19th Annual International Ultmann Chicago Lymphoma Symposium

Recent Advances in the Frontline Treatment of DLBCL: Is There a New …

Feat. L. Sehn
38:14
19th Annual International Ultmann Chicago Lymphoma Symposium

Cellular Therapy in Lymphoma: Where Are We Now?

Feat. P. Riedell
17:54
19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Thera…

Feat. T. Fenske
14:38
19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: We Should Stop Doing Autotransplants for Patients With MCL i…

Feat. P. Stiff
19:52
19th Annual International Ultmann Chicago Lymphoma Symposium

CLL: Present and Future

Feat. N. Lamanna
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

Feat. N. Mehta-Shah
20:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

Feat. L. Morton
28:22
19th Annual International Ultmann Chicago Lymphoma Symposium

Follicular Lymphoma Management in the COVID-19 Era

Feat. L. Gordon
41:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

Feat. K. Cohen
17:53
19th Annual International Ultmann Chicago Lymphoma Symposium

Sequencing of Therapies in R/R MCL

Feat. K. Maddocks
22:11
19th Annual International Ultmann Chicago Lymphoma Symposium

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differe…

Feat. D. Scott